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Abstract
Background: Composition of the vaginal microbiota has significant influence on female urogenital health and
control of infectious disease. Murine models are widely utilized to characterize host-pathogen interactions within
the vaginal tract, however, the composition of endogenous vaginal flora remains largely undefined with modern
microbiome analyses. Here, we employ 16S rRNA amplicon sequencing to establish the native microbial
composition of the vaginal tract in adult C57Bl/6 J mice. We further interrogate the impact of estrous cycle and
introduction of the human vaginal pathobiont, group B Streptococcus (GBS) on community state type and stability,
and conversely, the impact of the vaginal microbiota on GBS persistence.
Results: Sequencing analysis revealed five distinctive community states of the vaginal microbiota dominated largely
by Staphylococcus and/or Enterococcus, Lactobacillus, or a mixed population. Stage of estrus did not impact
microbial composition. Introduction of GBS decreased community stability at early timepoints; and in some mice,
GBS became the dominant bacterium by day 21. Endogenous Staphylococcus abundance correlated with GBS
ascension into the uterus, and increased community stability in GBS-challenged mice.
Conclusions: The murine vaginal flora is diverse and fluctuates independently of the estrous cycle. Endogenous flora
may impact pathogen colonization and dissemination and should be considered in urogenital infection models.
Keywords: Vaginal microbiome, Murine model, Estrous cycle, Group B Streptococcus, 16S rRNA sequencing
Background
The vaginal microbiota is intimately linked to women’s
health. In humans, the vaginal microbiota exists in 5 dis-
tinct community state types (CSTs) which are generally
dominated by Lactobacillus spp. [1]. Composition of the
microbiota varies in temporal stability, with greatest in-
stability exhibited during menses [2]. Subcategory CST
IV-A, a community dominated by facultative and strict
anaerobes in place of Lactobacillus spp. [1], has been as-
sociated with increased incidence of vulvovaginal atro-
phy [3], and colonization by group B Streptococcus
(GBS) [4]. Furthermore, vaginal dysbiosis, denoted clin-
ically as bacterial vaginosis (BV), is characterized as a
heterogeneous vaginal microbiota not dominated by a
single taxon [5]. BV or high bacterial diversity has been
associated with adverse health outcomes including pre-
term birth [6, 7], HIV acquisition [8, 9], and infection
with other urogenital pathogens including Trichomonas
vaginalis [10, 11], Chlamydia trachomatis [12], and
Neisseria gonorrhoeae [13]. The vaginal microbiota rep-
resents a key constituent of host-pathogen interactions
in the vaginal mucosa, with significant implications for
understanding susceptibility to disease and optimizing
prevention and treatment strategies.
Murine models of vaginal infection and colonization
are commonly used to characterize microbial pathogen-
esis determinants, host immune responses, and thera-
peutic interventions for urogenital pathogens including
HIV [14], group B Streptococcus [15], Candida albicans
[16, 17], Trichomonas vaginalis [18], Gardnerella vagi-
nalis [19], and Chlamydia trachomatis [20]. Despite the
widespread use of this animal model, the commensal
murine vaginal microbiota has yet to be longitudinally
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characterized with modern microbiome sequencing
methods. Earlier culture-based studies identified Entero-
bacteriaceae, Streptococcus spp., Staphylococcus spp.,
Corynebacterium spp., and Lactobacillus spp. among the
murine vaginal flora [21, 22], while 16S sequence-based
studies have either focused on select microbes of interest
[23] or have failed to account for estrus [24]. Variation
in vaginal communities across time and in relation to es-
trus have not been described.
Integrating detailed knowledge of the mouse vaginal
microbiota into host-pathogen infections can provide a
more direct application for these models to human uro-
genital pathogens. In this study, we characterize the
murine vaginal microbiota of the post-pubertal female
C57Bl/6 J Jackson mouse over time to assess the com-
position and stability of the vaginal flora throughout the
estrous cycle. We also introduce the vaginal commensal
bacterium and opportunistic pathogen, GBS to evaluate
microbiota changes in the context of a relevant human
infection model.
Results
Murine vaginal microbiota can be categorized into
distinct community state types
Little is known about the compositional stability of the
murine vaginal flora. Mice have short estrous cycles that
last 4–5 days and consist of four stages: proestrus, estrus,
metestrus, and diestrus [25].To assess stability of the
mouse vaginal microbiota in this context, we used one of
the most commonly utilized mouse strains/ages and
sources: post-pubertal 8-week-old female C57Bl/6 J mice,
obtained from Jackson Laboratories. Mice were received
at 7 weeks of age, randomized upon arrival into 5 mice
per cage, and acclimated over a one-week period. We
longitudinally sampled the vaginal microbiota every three
days over a period of 15 days by lavaging with
phosphate-buffered saline (PBS). We lavaged a second set
of mice only twice, on days 0 and 15, to test whether fre-
quent lavaging itself alters the microbiota. The corre-
sponding estrous cycle stage of each lavage sample was
determined by light microscopy. Samples were processed
for 16S rRNA gene sequencing as detailed in the Methods
section. Contaminants from sequencing reagents (primar-
ily Pseudomonas, Geobacillus, and Sphingobium reads) or
chloroplast and mitochondrial sequences were removed
before assessing community composition.
For comparison to earlier human vaginal microbiome
characterization studies [1, 2], samples were assigned
murine community state types (mCST) by hierarchical
clustering with Ward’s linkage of Euclidean distances
(Fig. 1) (silhouette score of 0.732), with the rarefied
OTU table at 1500 reads per sample. The most predom-
inant community state type, mCST I, consisted of
Staphylococcus-dominant flora. mCST II samples
contained vaginal flora comprised primarily of both
Staphylococcus and Enterococcus, while mCST III was
predominantly Enterococcus. mCST IV samples were Lac-
tobacillus-dominant and mCST V samples were not domi-
nated by either Staphylococcus or Enterococcus and had
higher alpha diversity (p < 0.001), Shannon diversity and
observed operational taxonomic units (OTU). Addition-
ally, there was one single sample dominated by Bifidobac-
terium, and this sample was excluded from subsequent
analyses as it was thought to be contaminated.
Murine vaginal community states are unstable
Interestingly, community states were relatively unstable
in mice. Of mice that had at least two successfully se-
quenced samples (at least 1500 reads/sample), 70% had
samples in at least two different community states
(Fig. 2). mCST I appeared to be the most stable commu-
nity state: for samples from consecutive timepoints that
successfully sequenced, 12/14 mCST I samples were
assigned mCST I at the next time point (Fig. 2). In com-
parison, only 1/5 samples in mCST II were also mCST
II at the next consecutive time point.
Estrous cycle does not impact vaginal community state type
After filtering and rarefaction to 1500 reads per sample,
few samples staged as diestrus and proestrus remained
(19.5 and 31.1% respectively) compared to estrus and met-
estrus (64.1, and 66.6% respectively, Fig. 3). Though se-
quencing success may vary over estrous cycle stage,
community state type was not significantly associated with
different stages in the estrous cycle (X2 = 17.29, p = 0.138).
A random forest classifier (scikit-learn) for estrous cycle
stage performed on the rarefied OTU table achieved an
accuracy of only 0.125, indicating that bacterial compos-
ition is a poor predictor of estrous cycle stage. Addition-
ally, beta diversity clustering for estrous cycle stage was
not significant and clustering by cage, stratified by day,
was only significant on days 0 and 9. (Fig. 4).
Group B Streptococcus challenge destabilizes vaginal
community states
To investigate how urogenital pathogens may perturb the
murine vaginal microbiota, we longitudinally sampled a
second cohort of mice experimentally challenged with
GBS and compared them to an uninfected control group.
These mice received intraperitoneal injection of 0.5 mg
β-estradiol 24 h before infection to synchronize estrus and
promote colonization [26]. Mice were lavaged and vagi-
nally inoculated with 1 × 107 colony forming units (CFU)
of a well characterized human serotype III GBS isolate
COH1 in 10 μl PBS or 10 μl PBS alone (control), then
lavaged 3, 7, 14, and 21 days after infection for micro-
biome sampling. GBS CFUs were also monitored by plat-
ing. On days 3, 14, and 21, twelve mice per group were
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sacrificed to determine bacterial tissue burdens. Lavage
samples were processed for 16S rRNA sequencing follow-
ing the same protocol as the staging cohort.
Although these mice were ordered in a separate ship-
ment, they exhibited similar vaginal microbiota and
community-state type clustering (Additional file 1).
Community state type mCST I consisted of Staphylococ-
cus-dominant flora and mCST II samples contained va-
ginal flora primarily comprised of Staphylococcus and
Enterococcus, and in some cases, Streptococcus reads
from GBS colonization. mCST VI samples were domi-
nated by GBS (Streptococcus), while mCST III was pre-
dominantly Enterococcus. Lactobacillus comprised most
of the flora in mCST IV samples and mCST V samples
consisted of a mix of bacteria. Streptococcus 16S reads
were only abundant in GBS-colonized mice and de-
blurred 16S sequences mapped to Streptococcus agalac-
tiae (GBS) in Genbank. To preserve more samples for
longitudinal analysis, samples were rarefied to 500 reads
per sample (rarefaction plots in Additional file 2).
Though mCST VI represented the GBS-dominant
state, GBS CFU determined by plating of vaginal lavage
samples was not significantly different at day 3 or 7
across all mCSTs (ANOVA p = 0.68, p = 0.75, respective-
ly)(Fig. 5a). However, by day 21 GBS CFU were only de-
tected in mice with mCST VI where GBS had
completely overtaken the vaginal flora (Fig. 5a). Initially,
GBS challenge significantly destabilized the vaginal
microbiota; pairwise Bray-Curtis distances between con-
secutive days for individual mice revealed significantly
increased distances in the GBS-challenged mice for days
3 (distance from day 0 to day 3) and 7 (distance between
days 3 and 7) (Fig. 5c). By day 21, the majority of the
GBS mice had GBS-dominant flora (mCST VI), signifi-
cantly reducing the pairwise distance between days 14
and 21 compared to PBS mice. To look specifically at
how changes in prominent taxa were contributing to the
initial increased pairwise sample distance with GBS
colonization while minimizing the effects of composi-
tionality, we took the log ratio of Staphylococcus relative
abundance over Streptococcus relative abundance or
GBS CFU and Enterococcus relative abundance over
Streptococcus relative abundance or GBS CFU. Correlat-
ing these log ratios to the Bray-Curtis distances between
the day 0 and day 3 samples within mice revealed that a
decrease in the ratio of Staphylococcus to Streptococcus
Fig. 1 Murine community state types and bacterial landscape of the murine vaginal microbiota. Samples are clustered by community state with
Ward’s linkage of Euclidean distances (silhouette score of 0.732, sklearn). Estrous cycle stage is depicted by shades of purple and bacterial
abundances are indicated by heatmap intensity corresponding to the colorbar ranging from purple to yellow
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or GBS CFU was significantly correlated with increased
distance between samples. Conversely, the ratio of En-
terococcus to Streptococcus had no significant correlation
with Bray-Curtis distance and the log ratio of Entero-
coccus relative abundance to GBS CFU was correlated
with reduced distance between samples (Fig. 6). As the
ratio of Staphylococcus to GBS is associated with com-
munity instability (distance), this suggests that turnover
of Staphylococcus for GBS is contributing to the increase
in pairwise distances.
For GBS-challenged mice, only 8/27 samples assigned
to mCST I remained mCST I at the next consecutive time
point. In comparison, control PBS mice had 19/27 mCST
I samples assigned mCST I at the next consecutive time
point. Additionally, mCST I mice exhibited significantly
higher CFU/g in the uterus on day 3 (Fig. 5b) and uterus
CFU was significantly correlated with Staphylococcus rela-
tive abundance (spearman, p = 0.0027), but this difference
was nullified at later time points. By day 21, only mCST
VI mice had GBS CFU remaining in vaginal, cervical, and
uterine tissue (Additional file 3).
Discussion
Like humans, laboratory mouse strain C57Bl/6 J exhibit
distinct vaginal microbiota community states (here
named mCSTs) generally dominated by single bacterial
taxa (Fig. 1). Three of the murine vaginal microbiota
mCSTs were dominated by bacteria from different gen-
era of Gram-positive facultative anaerobes: Staphylococ-
cus, Enterococcus, and Lactobacillus. This dramatic
variation in vaginal flora composition within an in-bred
strain of mice raises the question of whether the com-
mensal microbiota should be monitored in murine vagi-
nal colonization and infection models. It is also likely
that vaginal microbiota varies across vivaria, vendor, and
mouse strain. Previous studies have examined the vagi-
nal microbiota of BALB/c [24] and ICR mice [21]. In the
ICR study, culture-based techniques revealed frequent
presence of Streptococcus/Enterococcus, Staphylococcus,
Lactobacillus, and Gram-negative rods [21]. In the
BALB/c study, 16S amplicon sequencing described the
most abundant phyla were Firmicutes and Proteobac-
teria, with distinctive separation of vaginal communities
into two subclusters, one of which was dominated by
Streptococcus [24]. Although the consistent presence of
organisms such as Staphylococcus, Enterococcus, and
Lactobacillus suggest there may be a core set of vaginal
organisms across mouse strains, direct comparison of
our results with these studies is difficult due to differ-
ences in sampling and analyses and smaller sample size
(10 BALB/c mice and 27 ICR mice). Our findings indi-
cate that the urogenital pathogens under study may
Fig. 2 Vaginal Microbiome Stability. Mice from the cohort sampled every three days are displayed ordered by mouse and time point (left).
Missing samples indicate sequencing failure (< 1500 reads/sample) and point color depicts the community state type of the sample. Mice with
fewer than two successfully sequenced samples were excluded. Bray-Curtis distances between all samples from each individual mouse (right)
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encounter and interact with completely different com-
mensal vaginal flora, even within the same cage of mice,
potentially introducing variation and influencing experi-
mental outcomes.
Numerous studies have examined constituents control-
ling vaginal persistence in mice including innate and adap-
tive immune responses [27–29] and GBS regulatory and
virulence factors [30–32]. Additionally, several studies
have noted GBS in the vaginal lumen in close proximity to
native vaginal flora [29, 33]; however, none to date have
examined the role of native vaginal microbiota in this
model. Our study did not establish a definitive role for the
microbiota in experimental GBS challenge, and this may
be due to the high inoculum dose utilized in this model,
which typically achieves > 90% colonization within the first
week post-infection [26]. Future studies should examine a
titration of inoculum to reveal more subtle contributions
of the endogenous flora on GBS persistence. Nonetheless,
we did note the otherwise relatively stable Staphylococ-
cus-dominated CST I was perturbed by GBS challenge.
Mice with mCST I also exhibited increased GBS ascension
into uterine tissue by day 3. In multiple human studies,
GBS has been co-isolated with Staphylococcus spp. in both
pregnant and non-pregnant women [4, 34, 35]. Addition-
ally, in invasive GBS polymicrobial infections, S. aureus is
the most frequently co-isolated organism [36, 37]. One
study demonstrated induction of S. aureus toxic shock
syndrome toxin-1 by GBS culture supernatants in vitro
[38], but whether this phenomenon occurs in the vaginal
mucosa, or whether GBS virulence is also impacted, re-
mains to be described.
In humans, vaginal CST does not generally correlate
with GBS colonization status, except for the sub-group
CST IV-A, a non-Lactobacillus dominant state [4]. An-
tagonism between Lactobacillus and GBS has been re-
ported in both in vitro [39–41] and in vivo [42] model
systems. Oral probiotics containing Lactobacillus have
demonstrated efficacy in controlling GBS colonization in
pilot human trials [43, 44]. Likewise, in mice dominated
by Lactobacillus (CST IV), we were unable to detect any
GBS beyond day 7, however, our sample size was too
small (n = 2) to observed statistical differences. Further-
more, we observed that GBS was able to completely
overtake the vaginal microbiota in some mice (> 80% of
16S reads), even 21 days post-infection. These mice had
significantly higher GBS CFU over the course of the
study than mice with flora that was not taken over by
GBS on day 21 (student’s t-test, t-stat = 2.45, p = 0.018).
To our knowledge, the acquisition and maturation of
the murine vaginal microbiota has not yet been examined.
In this study, we used post-pubertal, non-pregnant mice,
8 weeks of age, which is a common age used to model
urogenital diseases [17, 26]. At this age, the estrous cycle
does not appear to influence the composition of the vagi-
nal microbiota, but does impact sequencing success (Fig.
3). In line with this observation, previous studies using
culture-based quantification have reported increased bac-
terial abundance in estrus compared to diestrus [21, 27,
45]. We selected vaginal lavage as our sampling method
due to precedence in the literature for > 90% bacterial re-
covery [45, 46] and for inter-sample consistency and col-
lection volume between our cohorts. To overcome the
low biomass resulting from vaginal lavage, future studies
may consider alternatives such as swabbing or scraping to
obtain more biomass from the mucosa. Though physi-
ology and immune cell populations fluctuate throughout
the estrous cycle, potential variability in bacterial abun-
dance provides further impetus for synchronization. The
precedence for steroid hormone administration to achieve
optimal infection of urogenital pathogens in murine
models supports this observation [47, 48].
While factors such as mouse strain, facility, and
vendor could certainly influence mCSTs as observed
with gut microbiota [49, 50], our two separate studies
and shipments of mice exhibited remarkable vaginal
mCST homogeneity (Additional file 1) with the excep-
tion of an emerging Streptococcus-dominated mCST in
GBS-infected mice. Future microbiome sequencing of
the murine vaginal microbiota extended to other ages,
strains, vendors, and vivaria, may reveal the existence of
more community states or sub-groups within mCSTs.
Fig. 3 Estrous cycle stage influences 16S rRNA sequencing success.
16S rRNA sequences after removing contaminants, mitochondria,
and chloroplast sequences (top). Images (bottom) depict
representative microscopy images from vaginal lavages in the
different estrous cycle stages, Magnification: 200X
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Conclusions
This current study is the first to our knowledge to
characterize the murine vaginal microbiota throughout
estrus using 16S rRNA sequencing. We further demon-
strate the influence of endogenous flora on successful
colonization and by a human pathogen. This work un-
derscores the importance of continuing to assess the na-
tive murine flora in models of human vaginal pathogens.
Methods
Mouse model and sample collection
All animal studies were reviewed and approved by the UC
San Diego Animal Care and Use Committee and con-
ducted using accepted veterinary standards. Mice were
maintained on a 12 h light/dark cycle, with controlled
temperature (19–22 °C) and 40–60% humidity. Mice were
fed a commercial diet (2020X, Teklad) and sterile water ad
libitum. See Additional file 4 for an overview of experi-
mental design. For the estrous staging study (Study 1),
7-week-old female C57Bl/6 J mice (n = 40) were purchased
from the Jackson Laboratory and housed five mice per
cage. Mice were allowed to acclimate for one week prior
to sample collection. To sample the vaginal microbiota,
mice were manually restrained, and lavaged twice with
50 μl of sterile phosphate-buffered saline (PBS) using
200 μl Gel-Loading pipet tips (Fisher Scientific) in a lam-
inar flow hood [26]. To control for environmental con-
tamination, each day that lavage was performed, we used
a single container of PBS, open in the hood during the en-
tire sampling time. Every pipette tip was introduced to the
same PBS container before lavaging. At the end of sample
collection, an aliquot of this PBS was collected and used
as a control for sequencing contamination. Twenty-five
mice were lavaged every 3 days for 15 days, and fifteen
mice were lavaged only twice, 15 days apart. After collect-
ing lavage samples, 3 μl was removed from each sample
for estrous cycle staging. Samples were visualized with a
Zeiss Observer.D1 microscope at 200X magnification and
the estrous cycle stage was identified independently by
two individuals with results corroborated. For the GBS
pathogen challenge study (Study 2), 7-week-old female
C57Bl/6 mice (n = 72) were purchased from the Jackson
Laboratory, housed four mice per cage, and allowed to ac-
climate for 1 week before infection. For GBS inoculation,
we utilized a previously described GBS vaginal
colonization model [26]. Briefly, mice were first injected
IP with 0.5mg of beta-estradiol suspended in 100 μl ses-
ame oil, and 24 h later, mice were vaginally inoculated
Fig. 4 Significant clustering by mCST, but not estrous stage. PCoA Plots of the Bray-Curtis distance matrix of mCST (top left), estrous stage (top
right), and cage (bottom). Clustering by mCST was significant (p = 0.001, pseudo-F-statistic = 52.13, by PERMANOVA with 999 permutations), while
clustering by estrous stage was not (p = 0.089, pseudo-F statistic = 1.69, by PERMANOVA 999 permutations). Clustering by cage was only
significant on days 0 (p = 0.002, pseudo-F-statistic = 3.00) and 9 (p = 0.001, pseudo-F-statistic = 35.5)
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with 1 × 107 CFU of GBS COH1 [51] in 10 μl of PBS or
PBS only as a control. Vaginal lavage sampling as de-
scribed above was performed on days 0, 3, 7, 14, and 21
post-inoculation. For tissue collection at days 3, 14, and
21, mice were sacrificed and vagina, cervix, and uterus dis-
sected and homogenized in PBS using 1mm silica beads
(Biospec) and shaken at 6000 rpm for 60 s using a MagNA
Lyser (Roche). To quantify bacterial burdens, tissue ho-
mogenates were diluted and plated on CHROMagar
StrepB (DRG International) to distinguish GBS CFU as
light pink or mauve colonies.
16S rRNA gene amplicon sequencing
Sample processing was performed following the Earth
Microbiome Project [52] DNA extraction and 16S se-
quencing protocol, detailed on the EMP website: http://
www.earthmicrobiome.org/protocols-and-standards/16s/
. In brief, lavage sample DNA was extracted using the
96-well MoBio Powersoil DNA kit. Barcoded 515F-806R
primers targeting the V4 region of the 16S rRNA gene
were used to for 16S amplification, and the resulting V4
amplicons were sequenced at UCSD Institute for Gen-
omic Medicine (IGM) on an Illumina MiSeq.
Sequencing analysis
Raw 16S sequencing data was demultiplexed in Qiita [53]
and processed using Deblur [54]. Microbiome data ana-
lysis, including feature table filtering, rarefaction, alpha di-
versity, beta diversity, and taxonomic assignments, was
performed with QIIME 2 [55] v 2017.10. Taxonomic as-
signments used the naive bayes sklearn classifier in QIIME
2 trained on the 515F/806R region of Greengenes 13_8
99% OTUs. As many of the samples were low biomass,
DNA contaminants from sequencing reagents and kits
had a substantial impact on the dataset. Negative controls
that went through the entire pipeline, from DNA extrac-
tion to sequencing, were used to catalog these contami-
nants. Sequences that appeared in negative controls were
Fig. 5 GBS colonization across community states. a GBS CFU recovered from vaginal lavage fluid and grouped according to mCST classification
on day 0. b GBS CFU recovered from tissues on day 3 and grouped according to mCST classification on day 0 c Bray-Curtis distance of vaginal
lavage sequences of GBS and PBS groups over time. Statistical significance indicated with asterisk (p < 0.05, Mann-Whitney U Test)
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removed from the lavage samples, excluding a sample-
abundant Lactobacillus sequence that was believed to be
well to well contamination. Mitochondria and chloroplast
16S sequences were also removed.
Community state types were assigned using the hier-
archical clustering with Ward’s linkage (SciPy) of Euclid-
ean distances calculated on a table rarefied to 1500
sequences per sample and validity of clusters assessed with
Silhouette Coefficient (sklearn). Data visualizations were
generated with the python packages seaborn [56], matplo-
tlib [57], and EMPeror [58] was used to create PCoA plots.
Statistical analysis was performed using SciPy [59] to
perform the Mann-Whitney U for comparing pathogen
CFU between mCSTs and Bray-Curtis distances between
PBS and GBS mice at individual timepoints, and to
perform spearman correlations for log ratios and
Bray-Curtis distance. PERMANOVA implemented in
QIIME 2 was used to assess statistical significance of
beta diversity clusters.
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Fig. 6 Community instability induced by GBS colonization correlates with Staphylococcus GBS turnover. Spearman correlations of pairwise Bray-Curtis
distance between day 0 and day 3 samples with the log ratio of Staphylococcus relative abundance over Streptococcus relative abundance (top left) or
GBS CFU (bottom left) and Enterococcus relative abundance over Streptococcus relative abundance (top right) or GBS CFU (bottom right)
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